Patents by Inventor Adelheid Cerwenka

Adelheid Cerwenka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of an anti-CD16A antibody with a cytokine
    Patent number: 11535672
    Abstract: The invention relates to an anti-CD16A antigen binding protein for use in NK cell-based immunotherapy, wherein the anti-CD16A antigen binding protein is to be administered intermittently and in combination with a cytokine. In certain embodiments the antigen binding protein is a tetravalent and bispecific CD30/CD16A tandem diabody.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: December 27, 2022
    Assignee: AFFIMED GMBH
    Inventors: Joachim Koch, Martin Treder, Jens Pahl, Uwe Reusch, Thorsten Ross, Erich Rajkovic, Adelheid Cerwenka
  • COMBINATION OF AN ANTI-CD16A ANTIBODY WITH A CYTOKINE
    Publication number: 20200010547
    Abstract: The invention relates to an anti-CD16A antigen binding protein for use in NK cell-based immunotherapy, wherein the anti-CD16A antigen binding protein is to be administered intermittently and in combination with a cytokine. In certain embodiments the antigen binding protein is a tetravalent and bispecific CD30/CD16A tandem diabody.
    Type: Application
    Filed: July 24, 2019
    Publication date: January 9, 2020
    Inventors: Joachim Koch, Martin Treder, Jens Pahl, Uwe Reusch, Thorsten Ross, Erich Rajkovic, Adelheid Cerwenka
  • B7-H6 therapeutically active monoclonal antibody against B7-H6 polypeptide
    Patent number: 9676855
    Abstract: The present invention is concerned with diagnostic methods and means. Specifically, it relates to an antibody which specifically binds to a portion of the extracellular domain of the B7-H6 polypeptide. Moreover, said antibody is provided for use in the treatment or diagnosis of cancer or inflammatory disease. Furthermore, provided are a method for diagnosing cancer in a sample of a subject suspected to suffer from cancer or an inflammatory disease. Further, the present invention concerns a device and a kit for diagnosing cancer or an inflammatory.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: June 13, 2017
    Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM
    Inventors: Adelheid Cerwenka, Gerhard Moldenhauer
  • B7-H6 THERAPEUTICALLY ACTIVE MONOCLONAL ANTIBODY AGAINST B7-H6 POLYPEPTIDE
    Publication number: 20140341915
    Abstract: The present invention is concerned with diagnostic methods and means. Specifically, it relates to an antibody which specifically binds to a portion of the extracellular domain of the B7-H6 polypeptide. Moreover, said antibody is provided for use in the treatment or diagnosis of cancer or inflammatory disease. Furthermore, provided are a method for diagnosing cancer in a sample of a subject suspected to suffer from cancer or an inflammatory disease. Further, the present invention concerns a device and a kit for diagnosing cancer or an inflammatory.
    Type: Application
    Filed: September 10, 2012
    Publication date: November 20, 2014
    Inventors: Adelheid Cerwenka, Gerhard Moldenhauer
  • Organic compounds
    Publication number: 20050079572
    Abstract: An isolated BSAP1, GID 2.1, GID 2.2, GID3 and GID4 gene expressed in dendritic cells of the immune system, BASP1, GID 2.1, GID 2.2, GID3 and GID4 polypeptides expressed by such gene and their function in the identification of compo8unds which are (ant)agonists to BASP1, GID 2.1, GID 2.2, GID3 and GID4 polypeptides.
    Type: Application
    Filed: July 16, 2002
    Publication date: April 14, 2005
    Inventors: Adelheid Cerwenka, Frank Kalthoff, William Phares